Montejo, AL, Majadas, S, Rico-Villademoros, F, Llorca, G, De La Gándara, J, Franco, M, et al. Frequency of sexual dysfunction in patients with a psychotic disorder receiving antipsychotics. J Sex Med
2010; 7: 3404–13.
Dossenbach, M, Hodge, A, Anders, M, Molnár, B, Peciukaitiene, D, Krupka-Matuszczyk, I, et al. Prevalence of sexual dysfunction in patients with schizophrenia: international variation and underestimation. Int J Neuropsychopharmacol
2005; 8: 195–201.
Macdonald, S, Halliday, J, MacEwan, T, Sharkey, V, Farrington, S, Wall, S, et al. Nithsdale Schizophrenia Surveys 24: sexual dysfunction. Case–control study. Br J Psychiatry
2003; 182: 50–6.
Howes, OD, Wheeler, MJ, Pilowsky, LS, Landau, S, Murray, RM, Smith, S. Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder. J Clin Psychiatry
2007; 68: 361–7.
Smith, SM, O'Keane, V, Murray, R. Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry
2002; 181: 49–55.
Baggaley, M. Sexual dysfunction in schizophrenia: focus on recent evidence. Hum Psychopharmacol
2008; 23: 201–9.
Raja, M, Azzoni, A. Sexual behavior and sexual problems among patients with severe chronic psychoses. Eur Psychiatry
2003; 18: 70–6.
Rosenberg, KP, Bleiberg, KL, Koscis, J, Gross, C. A survey of sexual side effects among severely mentally ill patients taking psychotropic medications: impact on compliance. J Sex Marital Ther
2003; 29: 289–96.
Olfson, M, Uttaro, T, Carson, WH, Tafesse, E. Male sexual dysfunction and quality of life in schizophrenia. J Clin Psychiatry
2005; 66: 331–8.
Ucok, A, Incesu, C, Aker, T, Erkoc, S. Do psychiatrists examine sexual dysfunction in schizophrenia patients?
J Sex Med
2008; 5: 2000–1.
Cutler, AJ. Sexual dysfunction and antipsychotic treatment. Psychoneuroendocrinology
2003; 28 (suppl 1): 69–82.
Westheide, J, Cohen, S, Bender, S, Cooper-Mahkorn, D, Erfurth, A, Gastpar, M, et al. Sexual dysfunction in psychiatric inpatients the role of antipsychotic medication. Pharmacopsychiatry
2007; 40: 140–5.
Malik, P, Kemmler, G, Hummer, M, Riecher-Roessler, A, Kahn, RS, Fleischhacker, WW, et al. Sexual dysfunction in first-episode schizophrenia patients: results from European first episode schizophrenia trial. J Clin Psychopharmacol
2011; 31: 274–80.
Broome, MR, Woolley, JB, Johns, LC, Valmaggia, LR, Tabraham, P, Gafoor, R, et al. Outreach and support in south London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state. Eur Psychiatry
2005; 20: 372–8.
Yung, AR, Yuen, HP, McGorry, PD, Phillips, LJ, Kelly, D, Dell'Olio, M, et al. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry
2005; 39: 964–71.
Yung, AR, Nelson, B, Stanford, C, Simmons, MB, Cosgrave, EM, Killackey, E, et al. Validation of ‘prodromal’ criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up. Schizophr Res
2008; 105: 10–7.
World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Clinical Description and Diagnostic Guidelines. WHO, 1992.
Wing, JK, Babor, T, Brugha, T, Burke, J, Cooper, JE, Giel, R, et al. SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry
1990; 47: 589–93.
Taylor, D, Paton, C, Kapur, S. The Maudsley Prescribing Guidelines (10th edn). Informa Healthcare, 2009.
Woods, SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry
2003; 64: 663–7.
Kay, SR, Fiszbein, A, Opler, LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull
1987; 13: 261–76.
Addington, D, Addington, J, Maticka-Tyndale, E, Joyce, J. Reliability and validity of a depression rating scale for schizophrenics. Schizophr Res
1992; 6: 201–8.
Nelson, HE, O'Connell, A. Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test. Cortex
1978; 14: 234–44.
Clayton, AH. Recognition and assessment of sexual dysfunction associated with depression. J Clin Psychiatry
2001; 62 (suppl 3): 5–9.
Bitter, I, Basson, BR, Dossenbach, MR. Antipsychotic treatment and sexual functioning in first-time neuroleptic-treated schizophrenic patients. Int Clin Psychopharmacol
2005; 20: 19–21.
Van Bruggen, M, van Amelsvoort, T, Wouters, L, Dingemans, P, de Haan, L, Linszen, D. Sexual dysfunction and hormonal changes in first episode psychosis patients on olanzapine or risperidone. Psychoneuroendocrinology
2009; 34: 989–95.
Aizenberg, D, Zemishlany, Z, Dorfman-Etrog, P, Weizman, A. Sexual dysfunction in male schizophrenic patients. J Clin Psychiatry
1995; 56: 137–41.
Uçok, A, Incesu, C, Aker, T, Erkoç, S. Sexual dysfunction in patients with schizophrenia on antipsychotic medication. Eur Psychiatry
2007; 22: 328–33.
Fan, X, Henderson, DC, Chiang, E, Briggs, LB, Freudenreich, O, Evins, AE, et al. Sexual functioning, psychopathology and quality of life in patients with schizophrenia. Schizophr Res
2007; 94: 119–27.
Cohen, S, Kühn, KU, Bender, S, Erfurth, A, Gastpar, M, Murafi, A, et al. Sexual impairment in psychiatric inpatients: focus on depression. Pharmacopsychiatry
2007; 40: 58–63.
Howes, OD, Montgomery, AJ, Asselin, MC, Murray, RM, Valli, I, Tabraham, P, et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry
2009; 66: 13–20.
Howes, O, Bose, S, Turkheimer, F, Valli, I, Egerton, A, Stahl, D, et al. Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study. Mol Psychiatry
2011; 16: 885–6.
Argiolas, A, Melis, MR. Central control of penile erection: role of the paraventricular nucleus of the hypothalamus. Prog Neurobiol
2005; 76: 1–21.
Knegtering, H, van den Bosch, R, Castelein, S, Bruggeman, R, Sytema, S, van Os, J. Are sexual side effects of prolactin-raising antipsychotics reducible to serum prolactin?
2008; 33: 711–7.
Wieck, A, Haddad, PM. Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review. Br J Psychiatry
2003; 182: 199–204.
Howes, OD, Wheeler, MJ, Meaney, AM, O'Keane, V, Fogelman, I, Blake, G, et al. Bone mineral density and its relationship to prolactin levels in patients taking antipsychotic treatment. J Clin Psychopharmacol
2005; 25: 259–61.
Howes, OD, Smith, S, Gaughran, FP, Amiel, SA, Murray, RM, Pilowsky, LS. The relationship between prolactin levels and glucose homeostasis in antipsychotic-treated schizophrenic patients. J Clin Psychopharmacol
2006; 26: 629–31.